Risk Factors Update Summary
- Expanded clinical trials to include Taiwan, beyond the United States, potentially impacting development timelines.
- Increased from 14 to 18 the number of factors affecting scalability and manufacturing costs.
- Added Current Good Manufacturing Practice (cGMP) compliance for clinical supply manufacturing.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1014763&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.